News & Updates

Show Multimedia Only

Biologics may improve synovitis, enthesitis in subclinical PsA patients

21 Jan 2026

Treatment with biologics results in short-term improvements of joint synovitis and enthesitis in patients with subclinical psoriatic arthritis (PsA), specifically for small joint synovitis, a study has shown.

Biologics may improve synovitis, enthesitis in subclinical PsA patients

21 Jan 2026

JSpADA passes disease measure validation for enthesitis-related, juvenile PsA

21 Jan 2026 by

A post hoc analysis of the JUNIPERA study has validated the Juvenile Spondyloarthritis Disease Activity Index (JSpADA) as a disease measure for children with enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (jPsA) in a prospective clinical trial setting, discriminating between active and inactive disease.

JSpADA passes disease measure validation for enthesitis-related, juvenile PsA

21 Jan 2026

Intralesional acyclovir on par with cryotherapy as treatment for plantar warts

21 Jan 2026

The use of intralesional acyclovir elicits similar efficacy to cryotherapy in the treatment of plantar warts, but the procedure is more painful, according to a study.

Intralesional acyclovir on par with cryotherapy as treatment for plantar warts

21 Jan 2026

Savolitinib + osimertinib a potential option for Chinese patients with EGFR-mutated, MET-amplified NSCLC

21 Jan 2026 by

Chinese patients with locally advanced or metastatic, EGFR-mutated, MET-amplified non-small-cell lung cancer (NSCLC) whose disease progressed on first-line (1L) EGFR tyrosine kinase inhibitor (TKI) therapy obtain progression-free survival (PFS) benefit from the all-oral combination of savolitinib plus osimertinib vs platinum-based doublet chemotherapy, interim results of the phase III SACHI trial have shown.

Savolitinib + osimertinib a potential option for Chinese patients with EGFR-mutated, MET-amplified NSCLC

21 Jan 2026

SG90 pinpoints modifiable factors for longevity in SG

21 Jan 2026 by

The SG90 cohort study fills knowledge gaps in healthy ageing in Singapore by identifying modifiable factors that contribute to longevity in the oldest-old.

SG90 pinpoints modifiable factors for longevity in SG

21 Jan 2026

Investigational TYK2 inhibitor looks good for atopic dermatitis

21 Jan 2026

The investigational tyrosine kinase 2 (TYK2) inhibitor ICP-332 shows promise in the treatment of atopic dermatitis (AD), with phase II data showing favourable safety profile and efficacy.

Investigational TYK2 inhibitor looks good for atopic dermatitis

21 Jan 2026

Redefining acute ischaemic stroke care: Advances in thrombolytics, neuroimaging and triage

21 Jan 2026 by

Recent advancements are revolutionizing acute ischaemic stroke (AIS) management. In an expert meeting, Professor Keith Muir, SINAPSE Professor of Clinical Imaging & Consultant Neurologist from the University of Glasgow, UK, alongside a panel of local neurologists, discussed innovative approaches to thrombolysis in complex AIS cases. The panel examined how different neuroimaging modalities and artificial intelligence (AI) technologies can aid diagnosis and expand the safe use of thrombolytics. They also explored recent revolutions, successes and challenges of stroke triage networks in Hong Kong and Scotland.

Redefining acute ischaemic stroke care: Advances in thrombolytics, neuroimaging and triage

21 Jan 2026

Parental disagreement over child ADHD diagnosis and care: Medicolegal considerations

21 Jan 2026 by

Parental disagreement over diagnosis and care of children with attention deficit hyperactivity disorder (ADHD) presents medicolegal challenges. This article discusses ways to navigate this situation.

Parental disagreement over child ADHD diagnosis and care: Medicolegal considerations

21 Jan 2026

Ethosuximide not supported for IBS pain management

20 Jan 2026

The T-type calcium channel blocker ethosuximide has shown limited benefit in the treatment of irritable bowel syndrome (IBS)-related abdominal pain in a proof-of-concept study.

Ethosuximide not supported for IBS pain management

20 Jan 2026

Low-dose olanzapine as good as megestrol acetate for cancer anorexia–cachexia syndrome

20 Jan 2026 by

For vulnerable cancer patients undergoing chemotherapy, treatment with low-dose olanzapine works just as well as megestrol acetate in terms of promoting appetite and weight gain, as shown in a study.

Low-dose olanzapine as good as megestrol acetate for cancer anorexia–cachexia syndrome

20 Jan 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Biologics may improve synovitis, enthesitis in subclinical PsA patients

Biologics may improve synovitis, enthesitis in subclinical PsA patients

JSpADA passes disease measure validation for enthesitis-related, juvenile PsA

JSpADA passes disease measure validation for enthesitis-related, juvenile PsA

Intralesional acyclovir on par with cryotherapy as treatment for plantar warts

Intralesional acyclovir on par with cryotherapy as treatment for plantar warts

Savolitinib + osimertinib a potential option for Chinese patients with EGFR-mutated, MET-amplified NSCLC

Savolitinib + osimertinib a potential option for Chinese patients with EGFR-mutated, MET-amplified NSCLC

SG90 pinpoints modifiable factors for longevity in SG

SG90 pinpoints modifiable factors for longevity in SG

Investigational TYK2 inhibitor looks good for atopic dermatitis

Investigational TYK2 inhibitor looks good for atopic dermatitis

Redefining acute ischaemic stroke care: Advances in thrombolytics, neuroimaging and triage

Redefining acute ischaemic stroke care: Advances in thrombolytics, neuroimaging and triage

Parental disagreement over child ADHD diagnosis and care: Medicolegal considerations

Parental disagreement over child ADHD diagnosis and care: Medicolegal considerations

Ethosuximide not supported for IBS pain management

Ethosuximide not supported for IBS pain management

Low-dose olanzapine as good as megestrol acetate for cancer anorexia–cachexia syndrome

Low-dose olanzapine as good as megestrol acetate for cancer anorexia–cachexia syndrome